1. Home
  2. BRVE vs ASTH Comparison

BRVE vs ASTH Comparison

Compare BRVE & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braveheart Bio Inc. Common Stock

BRVE

Braveheart Bio Inc. Common Stock

N/A

Current Price

$20.36

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

N/A

Current Price

$29.06

Market Cap

1.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
BRVE
ASTH
Founded
2024
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
BRVE
ASTH
Price
$20.36
$29.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$45.50
★ $51.89
AVG Volume (30 Days)
★ 473.2K
326.3K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.95
Revenue
N/A
★ $519,907,752.00
Revenue This Year
N/A
$24.87
Revenue Next Year
N/A
$9.94
P/E Ratio
★ N/A
$30.21
Revenue Growth
N/A
★ 45.90
52 Week Low
$16.70
$18.08
52 Week High
$32.00
$51.60

Technical Indicators

Market Signals
Indicator
BRVE
ASTH
Relative Strength Index (RSI) 49.49 30.89
Support Level $17.52 $23.00
Resistance Level $22.04 $40.18
Average True Range (ATR) 1.76 2.30
MACD 0.07 -0.65
Stochastic Oscillator 67.28 7.91

Price Performance

Historical Comparison
BRVE
ASTH

About BRVE Braveheart Bio Inc. Common Stock

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Share on Social Networks: